Starpharma Holdings Ltd (SPHRY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,470 | -5,355 | -10,528 | -11,720 | -14,744 |
| Depreciation Amortization | 693 | 731 | 803 | 783 | 699 |
| Accounts receivable | 1,203 | 1,354 | -846 | 456 | -1,770 |
| Accounts payable and accrued liabilities | -751 | -2,397 | -57 | 210 | 2,192 |
| Other Working Capital | 817 | -918 | -702 | -102 | -412 |
| Other Operating Activity | 130 | 2,009 | 2,218 | 824 | 2,970 |
| Operating Cash Flow | $-4,377 | $-4,576 | $-9,110 | $-9,549 | $-11,065 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | -58 | -418 | -607 | -184 |
| Sale Of Investment | N/A | N/A | 7 | 1 | N/A |
| Investing Cash Flow | $-27 | $-58 | $-411 | $-607 | $-184 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 328 | 581 | N/A | 2,902 | N/A |
| Common Stock Issued | N/A | N/A | N/A | N/A | 36,510 |
| Other Financing Activity | -1,059 | -3,694 | -468 | -560 | -1,912 |
| Financing Cash Flow | $-731 | $-3,113 | $-468 | $2,342 | $34,598 |
| Exchange Rate Effect | -16 | -5 | 67 | 136 | -600 |
| Beginning Cash Position | 15,128 | 23,071 | 33,605 | 43,893 | 22,456 |
| End Cash Position | 9,978 | 15,320 | 23,683 | 36,216 | 45,206 |
| Net Cash Flow | $-5,150 | $-7,752 | $-9,922 | $-7,677 | $22,749 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,377 | -4,576 | -9,110 | -9,549 | -11,065 |
| Capital Expenditure | -27 | -58 | -418 | -607 | -184 |
| Free Cash Flow | -4,404 | -4,634 | -9,529 | -10,156 | -11,248 |